Ultrasound Guided Subclavian Vein Cannulation at Emergency Room

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-11-01

Study Completion Date

2025-03-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

1. To observe and report the success rate associated with the use of ultrasound for subclavian vein catheterization.
2. To observe and report the type and complications and any constrains associated with this technique.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Central venous catheterisation is a commonly performed procedure in anaesthesia, critical care, acute and emergency medicine. 1 , the subclavian vein (SCV) has been an important vessel for central venous cannulation.2 The SCV cannulation offers several advantages when compared to the common alternative sites for central venous access. These advantages may include fewer cases of thrombosis, infectious complications, better patient comfort, and increased ability to remain patent in hypovolemic states.3-4 Traditionally, subclavian venous catheterisation has been performed using the landmark technique and because of the complications associated with this technique, it is not commonly performed.1 the complications such as catheter malposition, arterial puncture, hematoma, pneumothorax, hemothorax, and nerve injury.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ultrasound Subclavian Cannulation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Ultrasound

Use of ultrasound at subclavian vein cannulation for visualization

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All patient admitted to emergency room and indicated for central venous catheterization

Exclusion Criteria

* 1\. Any contraindication for central vein cannulation as coagulopathy, hemorrhage from target vessel, suspected proximal vascular injury 2- Age below 18 year

Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

ARMohamed

Resident

Responsibility Role PRINCIPAL_INVESTIGATOR

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Alshaima R Mohamed, Resident

Role: CONTACT

Phone: +2 01001960463

Email: [email protected]

Khaled S Mostafa, Professor

Role: CONTACT

Phone: +2 01283184028

Email: [email protected]

References

Explore related publications, articles, or registry entries linked to this study.

Hayashi M, Oshima K. Purification and properties of oxytocinase (cystine amino-peptidase) from monkey placenta. J Biochem. 1976 Aug;80(2):389-96. doi: 10.1093/oxfordjournals.jbchem.a131288.

Reference Type BACKGROUND

PMID: 12146 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Subclavian vein cannulation

Identifier Type: -

Identifier Source: org_study_id